NCT02358499View on ClinicalTrials.gov

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Fungal Infections
Interventions
DRUG

Posaconazole

Posaconazole will be given as a one time intravenous (IV) dose. The dose will take ninety (90) minutes to be infused and will be based on weight at the time of the visit.

Trial Locations (1)

64108

Children's Mercy Hospital Kansas City, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT02358499 - Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children | Biotech Hunter | Biotech Hunter